Baricitinib in chronic kidney disease: an exploratory analysis integrating network toxicology, molecular docking and pharmacovigilance.

Zheng R, Lu J, Deng M, Lyu J, Han J, Chen J, Wang Q, Liu Y, Yuan L, Bai Z

Open source

DOI
10.3389/fmed.2025.1717739
Published
2025
Container
Frontiers in medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2025.1717739,
  title = {Baricitinib in chronic kidney disease: an exploratory analysis integrating network toxicology, molecular docking and pharmacovigilance.},
  author = {Zheng R and Lu J and Deng M and Lyu J and Han J and Chen J and Wang Q and Liu Y and Yuan L and Bai Z},
  year = {2025},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2025.1717739},
  url = {https://doi.org/10.3389/fmed.2025.1717739}
}

RIS

TY  - JOUR
TI  - Baricitinib in chronic kidney disease: an exploratory analysis integrating network toxicology, molecular docking and pharmacovigilance.
AU  - Zheng R
AU  - Lu J
AU  - Deng M
AU  - Lyu J
AU  - Han J
AU  - Chen J
AU  - Wang Q
AU  - Liu Y
AU  - Yuan L
AU  - Bai Z
PY  - 2025
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2025.1717739
UR  - https://doi.org/10.3389/fmed.2025.1717739
ER  - 

APA

R, Z., J, L., M, D., J, L., J, H., J, C., Q, W., Y, L., L, Y., & Z, B. (2025). Baricitinib in chronic kidney disease: an exploratory analysis integrating network toxicology, molecular docking and pharmacovigilance.. Frontiers in medicine. https://doi.org/10.3389/fmed.2025.1717739

Source records